PFE
$33.88
Pfizer
$.32
.95%
PFE
Earnings Whisper ®
N/A
2nd Quarter June 2017
Consensus:  $0.65
Revenue:  $13.09 Bil
Tuesday
Aug 1
6:45 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS
Tuesday, May 02, 2017

What do you expect when PFE reports earnings?
Beat
Meet
Miss

Where is PFE's stock price going from here?
Up
Flat
Down
Stock chart of PFE
Analysts
Summary of analysts' recommendations for PFE
Score
Grade
Pivots
Resistance
$34.65
$34.37
$34.13

$33.85

Support
$33.61
$33.33
$33.09
Tweet
Growth
Description
Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company's diversified global healthcare portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and consumer healthcare products. Pfizer's Animal Health business unit discovers, develops and sells products for the prevention and treatment of diseases in livestock and companion animals. It sells its products to wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, veterinarians, livestock producers, and grocery and convenience stores. Pfizer Inc. is headquartered in New York.
Peers
Regeneron PharmaceuticalsCelgeneEli LillyVertex PharmaceuticalsBioMarin PharmaceuticalJohnson & JohnsonZoetisEndo International plcBristol-Myers SquibbMerck & Co.